Reuters logo
BRIEF-Shire and Parion Sciences enter into a collaborative license agreement
May 1, 2017 / 11:21 AM / in 6 months

BRIEF-Shire and Parion Sciences enter into a collaborative license agreement

May 1 (Reuters) - Shire Plc:

* Shire and Parion Sciences enter into a collaborative license agreement to advance p-321 for ophthalmic indications

* Demonstrates ongoing commitment to innovation in ophthalmics for Shire

* Shire Plc will make initial $20 million upfront license payment with an additional $20 million payment based on milestone

* Parion will be entitled to receive additional potential milestone payments, with a total potential deal value of up to $535 million

* Parion has option to co-fund through additional stages of development in exchange for enhanced tiered double-digit royalties.

* Parion also has option to co-fund commercialization activities and participate in financial outcome from those activities. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below